Inhibikase Therapeutics (IKT) EBT (2020 - 2026)
Inhibikase Therapeutics' EBT came in at -$21.05 million for Q2 2026, compared with -$10.83 million a year earlier.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) EBT (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Inhibikase Therapeutics reported EBT of -$65.44 million; for FY2025, it came in at -$51.97 million.
- Going back by year, EBT was -$28.59 million in FY2024, -$20.09 million in FY2023, -$18.13 million in FY2022 and -$14.79 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBT in data going back to Q1 2020.
- Business Quant data shows IKT's EBT at -$17.84 million (Q1 2026), -$13.78 million (Q4 2025) and -$12.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 34.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.83 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.96 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.06 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.39 Bn |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | -22.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -22.23 Mn |
| Jun 30, 2026 | -21.05 Mn |
| Mar 31, 2026 | -17.84 Mn |
| Dec 31, 2025 | -13.78 Mn |
| Sep 30, 2025 | -12.77 Mn |
| Jun 30, 2025 | -10.83 Mn |
| Mar 31, 2025 | -14.60 Mn |
| Dec 31, 2024 | -12.93 Mn |
| Sep 30, 2024 | -5.83 Mn |
| Jun 30, 2024 | -5.05 Mn |
| Mar 31, 2024 | -4.78 Mn |
| Dec 31, 2023 | -4.40 Mn |
| Sep 30, 2023 | -4.94 Mn |
| Jun 30, 2023 | -424.44 Bn |
| Mar 31, 2023 | -4.71 Mn |
| Dec 31, 2022 | -4.33 Mn |
| Sep 30, 2022 | -4.49 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.64 Mn |
| Dec 31, 2021 | -5.04 Mn |
API Access
Inhibikase Therapeutics EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();